HT
VRTX icon

Heritage Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Heritage Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,137
Closed -$742K – 235
2020
Q4 		$742K Sell
3,137
-190
-6% -$43.6K 0.12% 139
2020
Q3 		$906K Buy
3,327
+179
+6% +$49.4K 0.17% 114
2020
Q2 		$914K Buy
+3,148
New +$853K 0.18% 113
2019
Q1 		– Sell
-46
Closed -$8K – 418
2018
Q4 		$8K Hold
46
– – ﹤0.01% 326
2018
Q3 		$9K Hold
46
– – ﹤0.01% 330
2018
Q2 		$8K Hold
46
– – ﹤0.01% 322
2018
Q1 		$7K Hold
46
– – ﹤0.01% 309
2017
Q4 		$7K Hold
46
– – ﹤0.01% 303
2017
Q3 		$7K Hold
46
– – ﹤0.01% 300
2017
Q2 		$6K Hold
46
– – ﹤0.01% 270
2017
Q1 		$5K Buy
+46
New +$4.05K ﹤0.01% 284

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Heritage Trust's VRTX Position: Q1 2021 in Review

Heritage Trust sold out of Vertex Pharmaceuticals (VRTX) in Q1 2021, closing a stake of 3,137 shares — an estimated $742K sold.

Heritage Trust first reported a position in VRTX in Q1 2017 and held it in 11 quarters. The position peaked at $914K in Q2 2020. 999 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

  • Heritage Trust reported no remaining Vertex Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Heritage Trust sold 3,137 Vertex Pharmaceuticals shares in Q1 2021, an estimated $742K.
  • Heritage Trust first reported a position in Vertex Pharmaceuticals in Q1 2017 and held it in 11 quarters.
  • Heritage Trust's Vertex Pharmaceuticals position peaked at $914K in Q2 2020.
  • 999 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on Heritage Trust's 13F filing for Q1 2021, filed 12 May 2021.